KRAS and colorectal carcinoma: To examine the effect of somatic genetic changes in CRC that caused a response to anti-EGFR antibody therapy, a study was conducted to complete exome sequencing and copy number analyses of patient-derived tumor grafts and targeted genomic analyses of tumors, all of which were KRAS wild-type [11].